<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02520206</url>
  </required_header>
  <id_info>
    <org_study_id>SF11093</org_study_id>
    <nct_id>NCT02520206</nct_id>
  </id_info>
  <brief_title>Adenosylmethionine Metabolism in Human Inflammation</brief_title>
  <official_title>Translational Study on the Regulation of Adenosylmethionine Synthesis During Chronic Inflammation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Chung Hsing University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Science Council, Taiwan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministry of Science and Technology, Taiwan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>National Chung Hsing University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators propose to conduct a translational study on the regulation of&#xD;
      S-adenosylmethionine synthesis and cellular methylation reactions during chronic&#xD;
      inflammation. Development of in vitro cell models may reveal the regulatory mechanisms by&#xD;
      which specific inflammatory mediators cause metabolic changes and alter DNA methylation&#xD;
      status. Metabolic and pharmacological studies in the in vivo models will enable us to better&#xD;
      understand the regulation of inter-organ homeostasis of S-adenosyl methionine and help&#xD;
      identify tissue specific biomarkers for methylation and epigenetic modifications in different&#xD;
      stage of chronic inflammation. The clinical study in human subjects will help distinguish the&#xD;
      impacts of autoimmune rheumatic disease, degenerated joint disease, or specific medication&#xD;
      use on significant clinical and biochemical markers in folate and vitamin B6 metabolic&#xD;
      pathways.The Investigators hope the present study can identify specific clinical markers for&#xD;
      potential epigenetic changes in patients suffering from chronic inflammation, which will&#xD;
      contribute to better clinical management of these diseases in humans.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The significance of epigenetic alterations in autoimmune rheumatic diseases and degenerated&#xD;
      joint diseases has drawn great attention among clinicians and researchers. Aberrant&#xD;
      methylation status has been demonstrated in human chronic inflammation yet more efforts have&#xD;
      focused on global and sequence-specific hypomethylation and overexpression of specific genes.&#xD;
      Few studies investigated the regulation of S-adenosylmethionine homeostasis and regulation&#xD;
      during inflammation. At present the relevance and regulation of the complex epigenetic&#xD;
      profiles and their modifications among different tissues and organs during inflammation&#xD;
      remain largely unknown.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>January 2011</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>s-adenosylmethionine</measure>
    <time_frame>Blood were collected at admission. Some participants were followed for 4wks if medication was changed by the doctor</time_frame>
    <description>blood samples were collected and stored for later analyses of above metabolites</description>
  </primary_outcome>
  <primary_outcome>
    <measure>homocysteine</measure>
    <time_frame>Blood were collected at admission. Some participants were followed for 4wks if medication was changed by the doctor</time_frame>
    <description>blood samples were collected and stored for later analyses of above metabolites</description>
  </primary_outcome>
  <primary_outcome>
    <measure>folate</measure>
    <time_frame>Blood were collected at admission. Some participants were followed for 4wks if medication was changed by the doctor</time_frame>
    <description>blood samples were collected and stored for later analyses of above metabolites</description>
  </primary_outcome>
  <primary_outcome>
    <measure>vitamin B6</measure>
    <time_frame>Blood were collected at admission. Some participants were followed for 4wks if medication was changed by the doctor</time_frame>
    <description>blood samples were collected and stored for later analyses of above metabolites</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>blood amino acid profile (serine, glycine, methionine,cysteine, cystathionine, dimethylglycine)</measure>
    <time_frame>Blood were collected at admission. Blood were dawn again 1mo later if his medication was changed by the doctor</time_frame>
    <description>blood samples were collected and stored for later analyses of above metabolites</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>gene expression of target enzymes in PBMCs</measure>
    <time_frame>Blood were collected at admission.Blood were dawn again 1mo later if his medication was changed by the doctor</time_frame>
    <description>blood samples were collected and stored for later analyses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>enzyme activities of S-adenosylmethionine synthase in RBC</measure>
    <time_frame>Blood were collected at admission. Blood were dawn again 1mo later if his medication was changed by the doctor</time_frame>
    <description>blood samples were collected and stored for later analyses of above metabolites</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vitamin B6 metabolic enzyme in RBC</measure>
    <time_frame>Blood were collected at admission. Blood were dawn again 1mo later if his medication was changed by the doctor</time_frame>
    <description>blood samples were collected and stored for later analyses of above metabolites</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>polymorphisms in one carbon metabolism enzymes in PBMCs</measure>
    <time_frame>Blood were collected at admission. Blood were dawn again 1mo later if his medication was changed by the doctor</time_frame>
    <description>blood samples were collected and stored for later analyses</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Arthritis</condition>
  <condition>Chronic Inflammation</condition>
  <arm_group>
    <arm_group_label>Arthritis</arm_group_label>
    <description>subjects with arthritis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Health control subjects</arm_group_label>
    <description>Health control</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      plasma, RBC, PBMC&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients with arthritis or healthy adults&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  &gt; 18 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnancy,&#xD;
&#xD;
          -  anemia (hemoglobin 10 mg/dL or lower),&#xD;
&#xD;
          -  thrombocytopenia (platelet count below 50,000 cells/Î¼L),&#xD;
&#xD;
          -  abnormal serum hepatic transaminase (aspartate aminotransferase or alanine&#xD;
             aminotransferase above 50 IU/L),&#xD;
&#xD;
          -  diabetes or cancer&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>En-Pei I Chiang, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Food Science and Biotechnology, National Chung Hsing University</affiliation>
  </overall_official>
  <verification_date>August 2015</verification_date>
  <study_first_submitted>July 28, 2015</study_first_submitted>
  <study_first_submitted_qc>August 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2015</study_first_posted>
  <last_update_submitted>August 6, 2015</last_update_submitted>
  <last_update_submitted_qc>August 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Chung Hsing University</investigator_affiliation>
    <investigator_full_name>En-Pei Isabel Chiang</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

